Epinephrine inhalation aerosol (Kokua Pharma)

肾上腺素吸入气雾剂 (Kokua Pharma)

Report date: 2026/02/26 20:00:22

Base Information

Drug NameEpinephrine inhalation aerosol (Kokua Pharma)
Drug Alias NameKP-001
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsCLOVES SyndromeAnaphylaxisLymphatic Abnormalities +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesKokua Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesKokua Pharma IncKaken Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCLOVES SyndromeAnaphylaxisLymphatic Abnormalities +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A